drugset / Trial / NCT00206232

Novel Treatment for Diastolic Heart Failure in Women

NCT00206232

Phase 4 Completed 48 enrolled Baylor College of Medicine
RandomizedParallel-groupQuadruple-blindDiagnostic

Summary

The purpose of the study is to collect information about the potential benefit and safety of low dose spironolactone for a patient with diastolic heart failure (DHF) and to determine whether spironolactone can cause the patient's condition to improve.

Timeline

Start
2004-07
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Spironolactone Small molecule 25 mg

Indications